Tonix Pharm Hldg (TNXP) Misses Q2 EPS by 8c

Tonix Pharm Hldg (NASDAQ: TNXP) reported Q2 EPS of ($0.61), $0.08 worse than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Tonix Pharm Hldg (TNXP) click here.

You May Also Be Interested In

• Paychex (PAYX) Tops Q1 EPS by 2c
• AppLovin drops 3% as Edgewater analyst warns of stalled market share growth
• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion